Dermatology · Beloit, WI
NPI
1720097165
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1905 E. Huebbe Parkway, Beloit Health System Inc
Beloit, WI, 53511
Phone (608) 364-1219
Groups this clinician bills Medicare through
Medicare paid, 2024
$197K
9,356 services
Medicare patients, 2024
1,507
Average age 76
Drug cost, 2024
$194K
2,470 prescriptions
Company payments, 2025
$1,172
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul M Segal was code 17003 (destruction skin lesion), 3,086 times for 692 patients. In total Paul M Segal billed 9,356 services in 50 codes, and Medicare paid $197K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Facility | 3,086 | 692 | $1.36 | $4,212 |
| 17000 Destruction Skin Lesion | Facility | 1,462 | 920 | $35.62 | $52K |
| 17003 Destruction Skin Lesion | Office | 1,274 | 266 | $1.27 | $1,615 |
| 99213 Office E&M - Established | Facility | 857 | 538 | $42.61 | $37K |
| 99212 Office E&M - Established | Facility | 739 | 505 | $22.79 | $17K |
| 17000 Destruction Skin Lesion | Office | 526 | 337 | $34.14 | $18K |
| 99213 Office E&M - Established | Office | 318 | 198 | $43.99 | $14K |
| 99212 Office E&M - Established | Office | 225 | 154 | $21.53 | $4,845 |
| 11102 Skin Biopsy | Facility | 208 | 185 | $14.88 | $3,095 |
| 99202 Office E&M - New | Facility | 79 | 79 | $23.90 | $1,888 |
| 11602 Skin Lesion Excision | Facility | 66 | 55 | $84.54 | $5,580 |
| 11102 Skin Biopsy | Office | 62 | 60 | $16.04 | $995 |
| 11642 Skin Lesion Excision | Facility | 61 | 58 | $109.49 | $6,679 |
| 17004 Destruction Skin Lesion | Facility | 54 | 38 | $60.63 | $3,274 |
| 99202 Office E&M - New | Office | 34 | 34 | $22.42 | $762 |
By year: 2022 $196K for 9,031 services; 2023 $204K for 9,850 services; 2024 $197K for 9,356 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul M Segal prescribed most often to Medicare patients was Betamethasone Valerate, with 419 prescriptions and refills. In total Paul M Segal wrote 2,470 Medicare prescriptions that cost $194K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Valerate Generic | 419 | 502 | 216 | $11K |
| Triamcinolone Acetonide Generic | 364 | 478 | 198 | $3,761 |
| Fluocinonide Generic | 257 | 313 | 137 | $9,377 |
| Ketoconazole Generic | 212 | 248 | 109 | $4,210 |
| Metronidazole Generic | 195 | 252 | 110 | $11K |
| Doxycycline Monohydrate Generic | 174 | 408 | 67 | $4,478 |
| Alclometasone Dipropionate Generic | 109 | 123 | 78 | $4,949 |
| Hydrocortisone Generic | 96 | 98 | 51 | $691 |
| Fluticasone Propionate Generic | 69 | 75 | 29 | $1,584 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 57 | 64 | 35 | $2,161 |
| Minocycline Hcl Generic | 56 | 142 | 18 | $1,493 |
| Mometasone Furoate Generic | 46 | 52 | 17 | $997 |
| Valacyclovir Valacyclovir Hcl | 44 | 57 | 21 | $732 |
| Prednisone Generic | 38 | 41 | 24 | $268 |
| Mupirocin Generic | 35 | 36 | 23 | $170 |
Brand drugs: 385 claims; generic drugs: 2,085 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul M Segal $1,172 ($1,172 in general payments such as food, travel and fees) from 10 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $685.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 52 | $685 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $169 |
| UCB, Inc. UCB.BR | 4 | $100 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $45.16 |
| Organon LLC OGN | 2 | $41.42 |
| Abbvie Inc. ABBV | 2 | $37.09 |
| LEO Pharma Inc. | 2 | $32.31 |
| Arcutis Biotherapeutics, Inc. ARQT | 1 | $22.96 |
| Almirall LLC | 1 | $20.26 |
| Incyte Corporation INCY | 1 | $18.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.